Global Epigenetics Market 2017-2021
SKU ID : TNV-11196735 | Publishing Date : 14-Aug-2017 | No. of pages : 78
Detailed TOC of Global Epigenetics Market 2017-2021
Table of ContentsPART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
Market outline
PART 05: Market landscape
Market size and forecast
Five forces analysis
PART 06: Market segmentation by product
Global epigenetics market by product
Global epigenetics market by reagents
Global epigenetics market by kits
Global epigenetics market by others
PART 07: Geographical segmentation
Global epigenetics market by geography
Epigenetics market in Americas
Epigenetics market in EMEA
Epigenetics market in APAC
PART 08: Decision framework
PART 09: Drivers and challenges
Market drivers
Market challenges
PART 10: Market trends
Increasing use of epigenetics as a tool to understand development and disease
Increasing demand for personalized medicine
Rise in investment in R&D
PART 11: Vendor landscape
Competitive scenario
Investment opportunity analysis
PART 12: Key vendor analysis
Abcam
Bio-Rad Laboratories
Merck
Thermo Fisher Scientific
Other prominent vendors
PART 13: Appendix
List of abbreviations
List of Exhibits
Exhibit 01: Epigenetic changes in DNA
Exhibit 02: Normal cellular functions regulated by epigenetic mechanisms and molecular abnormalities caused by epigenetic errors
Exhibit 03: Global epigenetics market: Market overview
Exhibit 04: Global epigenetics market 2016-2021 ($ billions)
Exhibit 05: Factors impacting global epigenetics market
Exhibit 06: Five forces analysis
Exhibit 07: Global epigenetics market by product 2016-2021 (% share)
Exhibit 08: Global epigenetics market by product: Snapshot
Exhibit 09: Global epigenetics market by reagents 2016-2021 ($ billions)
Exhibit 10: Global epigenetic market by kits 2016-2021 ($ billions)
Exhibit 11: Global epigenetic market by others 2016-2021 ($ billions)
Exhibit 12: Global epigenetics market by geography 2016-2021 (% share)
Exhibit 13: Global epigenetics market by geography: Snapshot
Exhibit 14: Epigenetics market in Americas 2016-2021 ($ billions)
Exhibit 15: Epigenetics market in EMEA 2016-2021 ($ billions)
Exhibit 16: Epigenetics market in APAC 2016-2021 ($ billions)
Exhibit 17: Competitive parameters in global epigenetics market
Exhibit 18: Investment opportunity mapping
Exhibit 19: Strategic success factors for companies
Exhibit 20: Abcam: Company profile
Exhibit 21: Abcam: Strength analysis
Exhibit 22: Abcam: Strategy assessment
Exhibit 23: Abcam: Opportunity assessment
Exhibit 24: Bio-Rad Laboratories: Company profile
Exhibit 25: Bio-Rad Laboratories: Strength analysis
Exhibit 26: Bio-Rad Laboratories: Strategy assessment
Exhibit 27: Bio-Rad Laboratories: Opportunity assessment
Exhibit 28: Merck: Company profile
Exhibit 29: Merck: Strength analysis
Exhibit 30: Merck: Strategy assessment
Exhibit 31: Merck: Opportunity assessment
Exhibit 32: Thermo Fisher Scientific: Company profile
Exhibit 33: Thermo Fisher Scientific: Strength analysis
Exhibit 34: Thermo Fisher Scientific: Strategy assessment
Exhibit 35: Thermo Fisher Scientific: Opportunity assessment